Company overview
Asahi Kasei Bioprocess, under Asahi Kasei Life Science established in April 2025, provides virus removal filters like Planova™ and Microfilters BioOptimal™, along with CRO testing services via ViruSure and Bionique, and CDMO services through Bionova Scientific. These solutions support viral safety in cell culture media, downstream biopharmaceutical manufacturing, and emerging biologics modalities. The company is expanding Planova™ production capacity with a new facility in Japan starting operations in 2030 to meet global demand.
Asahi Kasei Bioprocess is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include virus removal filters, planova filters, bioprocess solutions, cro testing, cdmo services.
Industry categories: CRO & Clinical Services, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Asahi Kasei Bioprocess include Cdmo, Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://planova.ak-bio.com
- Categories
- CRO & Clinical Services, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- virus removal filters, planova filters, bioprocess solutions, cro testing, cdmo services
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What bioprocess products does Asahi Kasei Bioprocess offer?
- Key offerings include Planova™ virus removal filters (S20N, 15N, 20N, 35N, 75N), Microfilters BioOptimal™, and equipment for viral safety in biologics manufacturing and cell culture media.
- What are your CRO and CDMO capabilities?
- CRO testing services through ViruSure (Austria, acquired 2019) and Bionique (U.S., acquired 2021); CDMO services via Bionova Scientific (U.S., acquired 2022) for bioprocess development and manufacturing.
- Where are your manufacturing and service locations?
- Manufacturing in Japan (Nobeoka City for Planova™ filters, new plant by 2030); CRO in Austria and U.S.; CDMO in U.S., supporting global bioprocess supply chains.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
